appointments

R&D

There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.

News

Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.

News

Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.

News

Trump's FDA nominee Heidi Overton was quizzed on a range of issues at her Senate hearing, including vaccines, the abortion pill, and agency reforms.

R&D

Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August.

News

Six months after Paul Chaplin said he was stepping down as CEO of Bavarian Nordic, the Danish biopharma has named Tarja Stenvall to the role.